The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia

Saved in:
Bibliographic Details
Published inLeukemia Vol. 34; no. 9; pp. 2479 - 2483
Main Authors Godwin, Colin D., Laszlo, George S., Wood, Brent L., Correnti, Colin E., Bates, Olivia M., Garling, Eliotte E., Mao, Zhengwei J., Beddoe, Mary E., Lunn, Margaret C., Humbert, Olivier, Kiem, Hans-Peter, Walter, Roland B.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2020
Nature Publishing Group
Subjects
13
13/1
13/106
13/31
13/44
13/51
14
14/1
14/19
42
631/67/1990/283/1897
692/699/67/1059/2325
Acute myeloid leukemia
Antibody Specificity
Cancer Research
Cell Separation
Critical Care Medicine
Exons
Flow Cytometry
Health aspects
Hematology
Humans
Intensive
Internal Medicine
Letter
Leukemia
Leukemia, Myeloid, Acute - immunology
Leukemia, Myeloid, Acute - therapy
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Myeloid leukemia
Oncology
Protein Isoforms - genetics
Protein Splicing
Sialic Acid Binding Ig-like Lectin 3 - immunology
Sialic Acid Binding Ig-like Lectin 3 - metabolism
Therapeutic targets
Tumor Cells, Cultured
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
Shared first authorship
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-020-0755-7